Abbott India Ltd.

NSE: ABBOTINDIA | BSE: 500488 | ISIN: INE358A01014 | Industry: Pharmaceuticals
| Expensive Performer

logo
Abbott India Ltd.
12 May 2024, 12:00AM
ICICI Securities Limited
Abbott India’s (Abbott) Q4FY24 revenue growth of 7% was slightly below expectation of 9%; however, its 9.4% growth in FY24 was still ahead of industry growth of ~8%. Sequential drop of 197/407bps in gross/EBITDA margin was on account of higher third-party sourcing and higher overhead cost.
Abbott India Ltd. has an average target of 34729.60 from 5 brokers.
More from Abbott India Ltd.
Recommended